Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

MLTXMLTX
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in MoonLake Immunotherapeutics Class A

BANK OF AMERICA CORP /DE/ holds 751,897 shares of MLTX (MoonLake Immunotherapeutics Class A), worth $14.6M as of 2026-Q2. The position was increased (+3.7% shares). MLTX represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$14.6M

Current Shares

751,897

Total Value Change

+$12.2M

Total Shares Change

+706,357

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
751,897
+3.7%
$14.6M0.0%$19.47
29
2026-Q1
Increased
724,794
+5255.8%
$13.5M0.0%$17.69
45
2025-Q4
Increased
13,533
+198.6%
$178,3640.0%$13.21
25
2025-Q3
Increased
4,532
+64.7%
$32,4960.0%$6.24
20
2025-Q2
Decreased
2,751
-97.0%
$129,8480.0%$47.52
0
2025-Q1
Increased
91,174
+100.2%
$3.6M0.0%$39.86
43
2024-Q4
New
45,540
-
$2.5M0.0%$53.02
36

Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used